Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)
Clinical trial NCT03927170 · COMPLETED
Trial details
- NCT number
- NCT03927170
- Sponsor
- GL Pharm Tech Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-02
- Primary completion
- 2019-09-11
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.